State-of-the-art infrastructure built for biologics
From development to commercial supply, our GMP-certified sites ensure speed, scalability, and uncompromising quality
Why our facilities matter
Rezon Bio’s purpose-built facilities are designed to enable biologics from early development through commercial supply.
With GMP-certified manufacturing, quality control labs as well as R&D capabilities in Poland, our sites are strategically positioned to deliver speed, scalability, and quality.
Each location embodies our commitment to operational excellence, regulatory compliance, and client-centric execution, driven by experienced teams and industry-leading infrastructure.
GMP-certified manufacturing
R&D and QC Labs
Scalability from early to commercial supply
Experienced teams and compliance
Scalable, compliant biologics manufacturing in Gdańsk
Technical development and clinical batch production up to 2000+L, approved by EMA, FDA, and ROW
Gdańsk, Poland
Based in Gdańsk Science and Technology Park, our 7,500 m² R&D and manufacturing facility is one of Europe’s most modern. We provide client-tailored process development and GMP production of clinical and medium-scale commercial materials, supported by integrated QC, QA, and project management.
Innovative formulation
Our in-house capabilities include developing drug product formulations tested for stability per ICH guidelines. After internal development, processes can be scaled up and transferred to GMP-certified facilities or external partners.
Large-scale modular drug facility in Warsaw-Duchnice
State-of-the-art Warsaw-Duchnice facility driving scalable biopharmaceutical production.
Warsaw-Duchnice, Poland
Located in Warsaw, Poland’s capital, and built to serve the growing global demand for biopharmaceuticals, our commercial-scale GMP production facility, including QC Labs for drug substance is one of Europe’s largest and newest facilities.
Manufacturing expansion
The site adds significant drug substance manufacturing capacity at a 2,000L scale, plus single-use bioreactors from 50–500L for smaller batches. This enables cost-effective support for early-stage clinical trials and orphan drug production.
Where innovation
meets execution
- Whether you’re advancing a novel biologic or planning for commercial scale, Rezon Bio is ready to help you move forward with confidence
- Connect with our team to explore how our expertise, integrated solutions, and dedication can accelerate your success